ENGLEWOOD, Colo.
(Map)
-
ENGLEWOOD, Colo., March 28 /PRNewswire/ -- Baxa Corporation announces a
call for research papers involving its new PadLock(R) Set Saver product. The
PadLock device is designed to promote best practice for aseptic IV
administration set storage; preventing contamination of the administration set
when disconnected from the patient. The recently released product provides
temporary storage of the IV administration line between drug administrations,
replacing the need for single-use, sterile caps. Baxa is offering several
unrestricted grants for research studies on the usage and benefits of its new
product. Grants will be awarded for research intended for presentation at the
INS, AVA, APIC or similar meetings and/or publication in the Journal of
Infusion Nursing, Journal of Vascular Access, American Journal of Infection
Control or similar publications.
"We are interested in objective research studies on areas of interest to
healthcare providers, such as cost-benefit studies, aseptic techniques and
best practices," says Megan Kleckner, Product Manager of the announcement.
"Research studies regarding compliance with best practice and the reduction of
infection risks are also key targets." Professionals interested in pursuing
the grants should submit contact information and research ideas via email to
responses@baxa.com. Submissions will be reviewed and applicants responded to
by Baxa Corporation in a timely manner.
Baxa Corporation is a world leader in developing innovative technology for
the safe handling, packaging and administration of fluid medications in
hospital and alternate-care settings. Renowned for enhancing patient safety
and improving processes within pharmacy settings, with the PadLock Set Saver,
Baxa brings its expertise and experience to the patient bedside.
About Baxa Corporation
Baxa, a customer-focused medical device company, provides innovative,
solution-based technologies for medication handling and delivery. Its systems
and devices promote the safe and efficient preparation, handling, packaging,
and administration of medications. Key products include the PadLock(R) Set
Saver, Rapid-Fill(TM) Automated Syringe Fillers, Exacta-Med(R) Oral
Dispensers, MicroFuse(R) Syringe Infusers, Repeater(TM) Pharmacy Pumps, and
Exacta-Mix(TM) and MicroMacro(TM) Multi-Source Automated Compounders; used
worldwide in hospitals and healthcare facilities. Privately held, Baxa
Corporation has subsidiaries and sales offices in Canada and the United
Kingdom; direct representation in Austria, Belgium, Finland, France, Germany,
Luxembourg, The Netherlands and Switzerland; and distribution partners
worldwide. Further information is available at http://www.baxa.com.
Contact:
Marian Robinson, Vice President, Marketing
Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157
Email: marian.robinson@baxa.com
Maggie Chamberlin Holben, APR
Absolutely Public Relations: 303.984.9801 or 303.669.3558
Email: maggie@absolutelypr.com
